Moreover, the silencing of genes targeted by PAX7 (due to DUX4 activation) has been proposed as a pathological hallmark of muscle degeneration in FSHD [68,78]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.